Bernstein Lab Alumni
Postdoctoral Fellows and Instructors
Alexandre Gaspar-Maia, PhD
Current Position:
Assistant Professor
Laboratory of Functional Epigenomics
Mayo Clinic
Stabile 12-14
200 First Street SW
Rochester MN 55905
Maia.Alexandre@mayo.edu
(507) 293-2464
Chiara Vardabasso, PhD
Current Position:
Principal Scientist
Preclinical Pharmacology
Deerfield Discovery and Development
345 Park Avenue South, 12th floor
New York, NY 10010
cvardabasso@deerfield.com
Thomas Strub, PhD
Current Position:
Senior PostDoc
INSERM U1065 equipe 1
Centre Méditerranéen de Médecine Moléculaire Batiment Archimed
151 route Saint-Antoine de Ginestière
06204 Nice cedex 3
Tel: +33 (0) 4 89 06 43 33
thomas.strub@unice.fr
April Cook, PhD
Current Position:
Principal Scientist
Novo Nordisk
aprilcook@gmail.com
Flávia Ghiraldini, PhD
Current Position:
Cell Biologist
Protara Therapeutics, Inc.
345 Park Avenue South
New York, NY 10010
Sina Jostes, PhD
Graduate Students
Chi-Yeh (Jay) Chung, PhD
Current Position:
Associate Director of Bioinformatics
Plexium
San Diego, CA
jaychung0524@gmail.com
David Valle-Garcia, PhD
Current Position:
Assistant Professor
Neuroimmunology Department
National Institute of Neurology and Neurosurgery (Mexico)
david.valle@innn.edu.mx
Zulekha Qadeer, PhD
Current Position:
Postdoctoral Scholar
William A. Weiss Laboratory
University of California San Francisco
Zulekha was supported by: Department of Defense Peer Reviewed Cancer Research Program Horizon Award (2016-2017)
zulekha.qadeer@ucsf.edu
Zhen Sun
Current Position:
Charles Sawyers lab
Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
408 E 69th St, Z619, New York, NY 10065
sunz@mskcc.org
Saul Carcamo, PhD
Current Position:
Bioinformatician
Bioinformatics for Next Generation Sequencing (BiNGS) core
Tisch Cancer Institute at Mount Sinai
saul.carcamo@mssm.edu
Christie Nguyen
Current Position:
MSTP Program (Completing MD portion)
Icahn School of Medicine at Mount Sinai
christie.ryba@icahn.mssm.edu
School of Medicine Students
Joanna Dong
Joanna’s work focused on elucidating the H2A.Z-mediated regulation and pathogenesis of melanoma. H2A.Z is a histone variant with many interactors, including histone chaperone complexes and transcriptional regulators, with translational potential in melanoma pharmacotherapeutic development. She used loss-of-function screens and co-immunoprecipitation studies to establish the functional roles of these H2A.Z interactors in melanoma cells.